secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACHIEVE LIFE SCIENCES, INC. (ACHV)
CIK:        0000949858
Form:       8-K
Filed at:   2025-06-27T23:59:59+00:00
Accession:  0000950170-25-091055
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Achieve Life Sciences prices $45M offering: 15M shares and warrants at $3.00 per unit
--------------------------------------------------------------------------------

- Public offering of 15M shares of common stock and accompanying warrants to purchase up to 15M shares, priced at $3.00 per unit.
- Gross proceeds ~$45M; net proceeds ~$41.3M after underwriting discounts and expenses; expected close June 30, 2025.
- Underwriters granted 30-day option to purchase up to an additional 2.25M shares and/or warrants.
- Each warrant exercisable for one share at $3.00, or exchangeable for pre-funded warrant at $0.001/share; 5-year term; 9.99% ownership cap.
- Proceeds to fund cytisinicline advancement for smoking cessation through potential FDA approval and for working capital.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/949858/000095017025091055/0000950170-25-091055-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/949858/000095017025091055/achv-20250626.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-091055

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer